FDA Clearance Tracker · P980040-S161
TECNIS Symfony Extended Range Of Vision Intraocular Lens
Last checked: Nov 20, 2026Latest source record: Dec 22, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Dec 22, 2023
Approved
Time to decision
172 days
Received Jul 3, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P980040-S161
- Device name
- TECNIS Symfony Extended Range Of Vision Intraocular Lens
- Applicant location
- Irvine, CA
- Received
- Jul 3, 2023
- Decided
- Dec 22, 2023
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - PAS
- Original approval
- P980040
Device type
- Device class
- Class III
- Regulation
- 21 CFR 886.3600
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
approval of modifications to the final professional and patient labeling for the TECNIS Symfony Extended Range Of Vision Intraocular Lens (Models ZXR00 and ZXT 150-600) to include the results of your postmarket study.
Source documents
Other decisions for Johnson & Johnson Surgical Vision, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- TECNIS PureSee IOL, Model DEN00V TECNIS PureSee Toric II IOLs, Model DET150, DET225, DET300, DET375PMA supplement
P980040-S176 · Decided Mar 11, 2026 · 223 days after receipt · Panel Track
Device type: intraocular lens (HQL) · Ophthalmology
K223566 · Decided Apr 14, 2023 · 136 days after receipt
Device type: Ophthalmic Femtosecond Laser (OOE) · Ophthalmology
- TECNIS Synergy Intraocular Lens, TECNIS Synergy Toric II Intraocular Lens, TECNIS Synergy IOL with TECNIS Simplicity DelPMA supplement
P980040-S124 · Decided Apr 28, 2021 · 208 days after receipt · Panel Track
Device type: Lens, multifocal intraocular (MFK) · Ophthalmology
4 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.